Biomarkers for monitoring remodeling in a patient after a myocardial infarction
Posted in the Cardiology Forum
#1 Sep 2, 2011
A recent US patent application describes the use of biomarkers for monitoring success of remodeling in a patient after a myocardial infarction, wherein the remodeling is supported by treatment or a combination of treatments. A difference of 40% in inflammatory marker, osteopontin, indicates that administration of the drug can be lowered. A difference of 40% in inflammatory markers, osteopontin and GDF-15, indicates that administration of the drug can be lowered. A decrease to a difference of 33 pg/ml CRP indicates that administration of a drug can be lowered. News link: http://www.sciclips.com/sciclips/biomarker-ne...
Add your comments below
|Cardiologists, Veterinarian Work Together to Fi...||May 18||Go Blue Forever||4|
|Possible PVCs||May 10||Ashley12||1|
|heart rhythm off. skips a beat and speeds up fo... (Aug '08)||Apr 29||charlysmommy1||105|
|stress test EKG||Apr '15||Mercedes||1|
|Interpreting results of nuclear stress test (Jan '11)||Mar '15||Lynn||9|
|One in 4 patients who visited emergency departm...||Feb '15||LHIN||1|
|I think there is a serious error in the usual E...||Feb '15||Leonid Asipov||1|
Find what you want!
Search Cardiology Forum Now
Copyright © 2015 Topix LLC